Guggenheim initiates Nutanix stock with buy rating on VMware opportunity

Guggenheim initiated coverage of Nutanix with a Buy rating and a $100 price target, citing its opportunity to replace VMware in a $12 billion-plus hyperconverged infrastructure market. The firm forecasts revenue growth of 17% this year versus 13% consensus, accelerating to 20% by fiscal 2029; Nutanix reported an 86.93% trailing gross margin. Multiple other analysts have also raised price targets, while Guggenheim sees delayed on-premise revenue recognition becoming a tailwind by fiscal 2028, potentially as early as later this year.

Analysis

The investable signal is not the upgrade itself; it is whether VMware’s bundle-driven pricing turns into durable Nutanix workload migrations. If customers move, Nutanix can gain recurring software revenue and expand beyond core HCI through storage partnerships. But migration complexity and enterprise procurement cycles make this a quarters-long conversion story, not an immediate share-capture event. Broadcom’s VMware business is the clearest competitive exposure; hardware vendors and storage partners could benefit if migrations prompt infrastructure refreshes, though that depends on deployments rather than announced partnerships.

The bullish case is increasingly well advertised: multiple recent target increases can support near-term momentum but also raise the bar for execution. The key distinction is reported revenue versus underlying demand. Deferred on-premise revenue recognition may improve reported growth later without proving faster customer adoption. Likewise, the asserted software-defined compute opportunity is optionality until Nutanix shows storage-partner-led wins and expansion in ARR.

Over 1–3 months, watch ARR/net-new ARR, renewal and customer-conversion commentary, hardware availability, and guidance. Over 6–18 months, the thesis requires sustained migrations and attach beyond HCI. Risks include VMware customers accepting bundles, migration delays, competing cloud-native architectures, and supply or pricing constraints. The thesis weakens if ARR or net-new ARR decelerates, guidance is cut, or reported acceleration arrives without corresponding customer/ARR evidence.

Key Decisions for Investors

• NTNX: Prefer a staged long on weakness or after the next results confirm ARR and net-new ARR momentum; avoid chasing analyst-target headlines. Upside is continued share capture and broader storage/compute adoption; downside is multiple compression if migrations or growth disappoint.
• Treat Broadcom’s VMware pricing as a catalyst, not proof of churn. Monitor customer migration evidence and renewal commentary before expressing a relative-value short; VMware is not a separately mapped ticker here.
• Set an execution alert for the next guidance update: require evidence that storage partnerships are generating customer wins and that NC2 adoption is translating into recurring revenue, not just pipeline claims.
• Falsify the long thesis if management lowers growth guidance, ARR/net-new ARR trends weaken, or delayed revenue recognition lifts reported revenue without improving underlying demand. No options trade is warranted without a clearer catalyst date and volatility context.